Abstract

Background: Neonatal hypoglycemia (NH) is a common disorder affecting 5 to 15% of otherwise healthy infants, such as late preterm, small or large for gestational age, or born to mothers with diabetes. Early management of NH in these at-risk infants is often achieved with administration of formula and/or intravenous (IV) dextrose, which may potentially impair normal metabolic adaptation. Multiple studies have demonstrated that early infant skin-to-skin contact with …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call